CTOs on the Move

Lensar

www.lensar.com

 
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.lensar.com
  • 2800 Discovery Drive
    Orlando, FL USA 32826
  • Phone: 888.536.7271

Executives

Name Title Contact Details

Similar Companies

Medi-Globe Corporation

Medi-Globe Corporation is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heatmax inc

Heatmax inc is a Dalton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeScan

LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.

Canadian Health Care Products

Canadian Health Care Products is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pulse Biosciences

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company`s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS`s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death.